REFERENCES
- Tareke E, Rydberg P, Karlsson P, Eriksson S, and Tornqvist M: Analysis of acrylamide, a carcinogen formed in heated foodstuffs. J Agric Food Chem 50, 4998–5006, 2002.
- Mottram DS, Wedzicha BL, and Dodson AT: Acrylamide is formed in the Maillard reaction. Nature 419, 448–449, 2002.
- Stadler RH, Blank I, Varga N, Robert F, Hau J, et al.: Acrylamide from Maillard reaction products. Nature 419, 449–450, 2002.
- Elmore JS, Koutsidis G, Dodson AT, Mottram DS, and Wedzicha BL: The effect of cooking on acrylamide and its precursors in potato, wheat and rye. Adv Exp Med Biol 561, 255–269, 2005.
- Ishihara K, Matsunaga A, Miyoshi T, Nakamura K, Nakayama T, et al.: Formation of acrylamide in a processed food model system, and examination of inhibitory conditions. Shokuhin Eiseigaku Zasshi 46, 33–39, 2005.
- Lukac H, Amrein TM, Perren R, Conde-Petit B, Amado R, et al.: Influence of roasting conditions on the acrylamide content and the color of roasted almonds. J Food Sci 72, C033–C038, 2007.
- Amrein TM, Bachmann S, Noti A, Biedermann M, Barbosa MF, et al.: Potential of acrylamide formation, sugars, and free asparagine in potatoes: a comparison of cultivars and farming systems. J Agric Food Chem51, 5556–5560, 2003.
- De WT, De MB, Mestdagh F, Govaert Y, Vandeburie S, et al.: Influence of fertilization on acrylamide formation during frying of potatoes harvested in 2003. J Agric Food Chem 54, 404–408, 2006.
- Chuda Y, Ono H, Yada H, Ohara-Takada A, Matsuura-Endo C, et al.: Effects of physiological changes in potato tubers (Solanum tuberosum L.) after low temperature storage on the level of acrylamide formed in potato chips. Biosci Biotechnol Biochem 67, 1188–1190, 2003.
- Biedermann-Brem S, Noti A, Grob K, Imhof D, Bazzacco D, et al.: How much reducing sugar may potatoes contain to aviod excessive acrylamide formation during roasting and baking? Eur Food Res Technol 217, 369–373, 2003.
- Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA: A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer. Cancer Epidemiol Biomarkers Prev 16, 2304–2313, 2007.
- Larsson SC, Akesson A, and Wolk A: Dietary acrylamide intake and prostate cancer risk in a prospective cohort of Swedish men. Cancer Epidemiol Biomarkers Prev 18, 1939–1941, 2009.
- Larsson SC, Akesson A, and Wolk A: Long-term dietary acrylamide intake and breast cancer risk in a prospective cohort of Swedish women. Am J Epidemiol 169, 376–381, 2009.
- Larsson SC, Akesson A, and Wolk A: Long-term dietary acrylamide intake and risk of epithelial ovarian cancer in a prospective cohort of Swedish women. Cancer Epidemiol Biomarkers Prev 18, 994–997, 2009.
- Larsson SC, Hakansson N, Akesson A, and Wolk A: Long-term dietary acrylamide intake and risk of endometrial cancer in a prospective cohort of Swedish women. Int J Cancer 124, 1196–1199, 2009.
- Mucci LA, Sandin S, Balter K, Adami HO, Magnusson C, et al.: Acrylamide intake and breast cancer risk in Swedish women. JAMA 293, 1326–1327, 2005.
- Pedersen GS, Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, et al.: Dietary acrylamide intake and estrogen and progesterone receptor-defined postmenopausal breast cancer risk. Breast Cancer Res Treat 122, 199–210, 2010.
- Pelucchi C, Galeone C, Levi F, Negri E, Franceschi S, et al.: Dietary acrylamide and human cancer. Int J Cancer 118, 467–471, 2006.
- Wilson KM, Mucci LA, Cho E, Hunter DJ, Chen WY, et al.: Dietary acrylamide intake and risk of premenopausal breast cancer. Am J Epidemiol 169, 954–961.
- Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, van den Brandt PA. Dietary acrylamide intake is not associated with gastrointestinal cancer risk. J Nutr 138, 2229–2236, 2008.
- Larsson SC, Akesson A, Bergkvist L, and Wolk A: Dietary acrylamide intake and risk of colorectal cancer in a prospective cohort of men. Eur J Cancer 45, 513–516, 2009.
- Mucci LA, Dickman PW, Steineck G, Adami HO, and Augustsson K: Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden. Br J Cancer 88, 84–89, 2003.
- Mucci LA, Adami HO, and Wolk A: Prospective study of dietary acrylamide and risk of colorectal cancer among women. Int J Cancer 118, 169–173, 2006.
- Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA: Dietary acrylamide intake and the risk of renal cell, bladder, and prostate cancer. Am J Clin Nutr 87, 1428–1438, 2008.
- Mucci LA, Lindblad P, Steineck G, and Adami HO: Dietary acrylamide and risk of renal cell cancer. Int J Cancer 109, 774–776, 2004.
- Pelucchi C, Galeone C, Dal ML, Talamini R, Montella M, et al.: Dietary acrylamide and renal cell cancer. Int J Cancer 120, 1376–1377, 2007.
- Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA. Lung cancer risk in relation to dietary acrylamide intake. J Natl Cancer Inst 101, 651–662, 2009.
- Hogervorst JG, Schouten LJ, Konings EJ, Goldbohm RA, and van den Brandt PA: Dietary acrylamide intake and brain cancer risk. Cancer Epidemiol Biomarkers Prev 18, 1663–1666, 2009.
- Olesen PT, Olsen A, Frandsen H, Frederiksen K, Overvad K, et al.: Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study. Int J Cancer 122, 2094–2100, 2008.
- Wilson KM, Balter K, Adami HO, Gronberg H, Vikstrom AC, et al.: Acrylamide exposure measured by food frequency questionnaire and hemoglobin adduct levels and prostate cancer risk in the Cancer of the Prostate in Sweden Study. Int J Cancer 124, 2384–2390, 2009.
- Mucci LA and Wilson KM: Acrylamide intake through diet and human cancer risk. J Agric Food Chem 56, 6013–6019, 2008.
- U.S. Food and Drug Administration: Survey Data on Acrylamide in Food: Total Diet Study. . Revitrieved from http://www.fda.govov/Food/FoodSafety/FoodContaminantsAdulteration/ChemicalContaminants /Acrylamide /ucm053566htm2004
- U.S. Food and Drug Administration: Survey Data on Acrylamide in Food: Individual Food Products. . Retrieved from http://www.fda.gov/Food/FoodSafety/FoodContaminantsAdulteration/ChemicalContamiChems/Acrylamide/ucm053549.htm#u1004
- Fuhr U, Boettcher MI, Kinzig-Schippers M, Weyer A, Jetter A, et al.: Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity. Cancer Epidemiol Biomarkers Prev 15, 266–271, 2006.
- Hogervorst JG, Baars BJ, Schouten LJ, Konings EJ, Goldbohm RA, et al.: The carcinogenicity of dietary acrylamide intake: a comparative discussion of epidemiological and experimental animal research. Crit Rev Toxicol 40, 485–512, 2010.
- Pelucchi C, La VC, Bosetti C, Boyle P, and Boffetta P: Exposure to acrylamide and human cancer—a review and meta-analysis of epidemiologic studies. Ann Oncol 7, 1487–1499, 2011.
- Fennell TR, Sumner SC, Snyder RW, Burgess J, Spicer R, et al.: Metabolism and hemoglobin adduct formation of acrylamide in humans. Toxicol Sci 85, 447–459, 2005.
- Fennell TR, Sumner SC, Snyder RW, Burgess J, and Friedman MA: Kinetics of elimination of urinary metabolites of acrylamide in humans. Toxicol Sci 93, 256–267, 2006.
- Bergmark E, Calleman CJ, and Costa LG: Formation of hemoglobin adducts of acrylamide and its epoxide metabolite glycidamide in the rat. Toxicol Appl Pharmacol 111, 352–363, 1991.
- Bergmark E, Calleman CJ, He F, and Costa LG: Determination of hemoglobin adducts in humans occupationally exposed to acrylamide. Toxicol Appl Pharmacol 120, 45–54, 1993.
- Sumner SC, Fennell TR, Moore TA, Chanas B, Gonzalez F, et al.: Role of cytochrome P450 2E1 in the metabolism of acrylamide and acrylonitrile in mice. Chem Res Toxicol 12, 1110–1116, 1999.
- Taubert D, Glockner R, Muller D, and Schomig E: The garlic ingredient diallyl sulfide inhibits cytochrome P450 2E1 dependent bioactivation of acrylamide to glycidamide. Toxicol Lett 164, 1–5, 2006.
- Ghanayem BI, Witt KL, Kissling GE, Tice RR, and Recio L: Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect. Mutat Res 578, 284–297, 2005.
- Fennell TR, Sumner SC, and Walker VE: A model for the formation and removal of hemoglobin adducts. Cancer Epidemiol Biomarkers Prev 1, 213–219, 1992.
- Schettgen T, Rossbach B, Kutting B, Letzel S, Drexler H, et al.: Determination of haemoglobin adducts of acrylamide and glycidamide in smoking and non-smoking persons of the general population. Int J Hyg Environ Health 207, 531–539, 2004.
- Urban M, Kavvadias D, Riedel K, Scherer G, and Tricker AR: Urinary mercapturic acids and a hemoglobin adduct for the dosimetry of acrylamide exposure in smokers and nonsmokers. Inhal Toxicol 18, 831–839, 2006.
- Vesper HW, Caudill SP, Osterloh JD, Meyers T, Scott D, et al.: Exposure of the U.S. population to acrylamide in the National Health and Nutrition Examination Survey 2003–2004. Environ Health Perspect 118, 278–283, 2010.
- Dybing E, Farmer PB, Andersen M, Fennell TR, Lalljie SP, et al.: Human exposure and internal dose assessments of acrylamide in food. Food Chem Toxicol 43, 365–410, 2005.
- Svensson K, Abramsson L, Becker W, Glynn A, Hellenas KE, et al.: Dietary intake of acrylamide in Sweden. Food Chem Toxicol 41, 1581–1586, 2003.
- Konings EJ, Baars AJ, van Klaveren JD, Spanjer MC, Rensen PM, et al.: Acrylamide exposure from foods of the Dutch population and an assessment of the consequent risks. Food Chem Toxicol 41, 1569–1579, 2003.
- Schettgen T, Kutting B, Hornig M, Beckmann MW, Weiss T, et al.: Trans-placental exposure of neonates to acrylamide—a pilot study. Int Arch Occup Environ Health 77, 213–216, 2004.
- Magnus P, Irgens LM, Haug K, Nystad W, Skjaerven R, et al.: Cohort profile: the Norwegian Mother and Child Cohort Study (MoBa). Int J Epidemiol 35, 1146–1150, 2006.
- Kutting B, Uter W, and Drexler H: The association between self-reported acrylamide intake and hemoglobin adducts as biomarkers of exposure. Cancer Causes Control 19, 273–281, 2008.
- Ferrari P, Freisling H, Duell EJ, Kaaks R, Lujan-Barroso L, et al.: Challenges in estimating the validity of dietary acrylamide measurements. Eur J Nutr 5, 1503–1512, 2013.
- Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, et al.: European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr 5, 1113–1124, 2002.
- Wilson KM, Mucci LA, Rosner BA, and Willett WC: A prospective study of dietary acrylamide intake and the risk of breast, endometrial, and ovarian cancers. Cancer Epidemiol Biomarkers Prev 10, 2503–2515, 2010.
- Hirvonen T, Kontto J, Jestoi M, Valsta L, Peltonen K, et al.: Dietary acrylamide intake and the risk of cancer among Finnish male smokers. Cancer Causes Control 21, 2223–2229, 2010.
- Satia JA, Littman A, Slatore CG, Galanko JA, and White E: Long-term use of beta-carotene, retinol, lycopene, and lutein supplements and lung cancer risk: results from the VITamins And Lifestyle (VITAL) study. Am J Epidemiol 169, 815–828, 2009.
- Slatore CG, Littman AJ, Au DH, Satia JA, and White E: Long-term use of supplemental multivitamins, vitamin C, vitamin E, and folate does not reduce the risk of lung cancer. Am J Respir Crit Care Med 177, 524–530, 2008.
- Wright ME, Groshong SD, Husgafvel-Pursiainen K, Genova E, Lucia MS, et al.: Effects of beta-carotene supplementation on molecular markers of lung carcinogenesis in male smokers. Cancer Prev Res (Phila) 3, 745–752, 2010.
- Wilson KM, Giovannucci E, Stampfer MJ, and Mucci LA: Dietary acrylamide and risk of prostate cancer. Int J Cancer 131, 479–487, 2012.
- van den Brandt PA, Goldbohm RA, van't Veer P, Volovics A, Hermus RJ, et al.: A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol43, 285–295, 1990.
- Schouten LJ, Hogervorst JG, Konings EJ, Goldbohm RA, and van den Brandt PA: Dietary acrylamide intake and the risk of head-neck and thyroid cancers: results from the Netherlands Cohort Study. Am J Epidemiol 170, 873–884, 2009.
- Bongers ML, Hogervorst JG, Schouten LJ, Goldbohm RA, Schouten HC, et al. Dietary acrylamide intake and the risk of lymphatic malignancies: the Netherlands Cohort Study on diet and cancer. PLoS One7(62012.
- Cade JE, Burley VJ, and Greenwood DC: The UK Women's Cohort Study: comparison of vegetarians, fish-eaters and meat-eaters. Public Health Nutr 7, 871–878, 2004.
- Burley VJ, Greenwood DC, Hepworth SJ, Fraser LK, de Kok TM, et al.: Dietary acrylamide intake and risk of breast cancer in the UK women's cohort. Br J Cancer 103, 1749–1754, 2010.
- Tjonneland A, Olsen A, Boll K, Stripp C, Christensen J, et al.: Study design, exposure variables, and socioeconomic determinants of participation in Diet, Cancer and Health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35, 432–441, 2007.
- Xie J, Terry KL, Poole EM, Wilson KM, Rosner BA, et al.: Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control study. Cancer Epidemiol Biomarkers Prev 22, 653–660, 2013.
- Augustsson K, Skog K, Jagerstad M, Dickman PW, and Steineck G: Dietary heterocyclic amines and cancer of the colon, rectum, bladder, and kidney: a population-based study. Lancet 353, 703–707, 1999.
- Augustsson K, Skog K, Jagerstad M, and Steineck G: Assessment of the human exposure to heterocyclic amines. Carcinogenesis 18, 1931–1935, 1997.
- Hagmar L and Tornqvist M: Inconclusive results from an epidemiological study on dietary acrylamide and cancer. Br J Cancer 89, 774–775, 2003.
- Lindblad P, Wolk A, Bergstrom R, and Adami HO: Diet and risk of renal cell cancer: a population-based case-control study. Cancer Epidemiol Biomarkers Prev 6, 215–223, 1997.
- Hedelin M, Balter KA, Chang ET, Bellocco R, Klint A, et al.: Dietary intake of phytoestrogens, estrogen receptor-beta polymorphisms and the risk of prostate cancer. Prostate 66, 1512–1520, 2006.
- Lin Y, Lagergren J, and Lu Y: Dietary acrylamide intake and risk of esophageal cancer in a population-based case-control study in Sweden. Int J Cancer 128, 676–681, 2011.
- Lagergren J, Bergstrom R, Lindgren A, and Nyren O: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340, 825–831, 1999.
- Pelucchi C, Franceschi S, Levi F, Trichopoulos D, Bosetti C, et al.: Fried potatoes and human cancer. Int J Cancer 105, 558–560, 2003.
- Soler M, Bosetti C, Franceschi S, Negri E, Zambon P, et al.: Fiber intake and the risk of oral, pharyngeal and esophageal cancer. Int J Cancer 91, 283–287, 2001.
- Levi F, Pasche C, Lucchini F, Chatenoud L, Jacobs DR, et al.: Refined and whole grain cereals and the risk of oral, oesophageal and laryngeal cancer. Eur J Clin Nutr 54, 487–489, 2000.
- Bosetti C, La VC, Talamini R, Negri E, Levi F, et al.: Food groups and laryngeal cancer risk: a case-control study from Italy and Switzerland. Int J Cancer 100, 355–360, 2002.
- La VC, Braga C, Negri E, Franceschi S, Russo A, et al.: Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer 73, 525–530, 1997.
- Tavani A, Gallus S, La VC, Dal ML, Negri E, et al.: Physical activity and risk of ovarian cancer: an Italian case-control study. Int J Cancer 91, 407–411, 2001.
- Franceschi S, Favero A, Decarli A, Negri E, La VC, et al.: Intake of macronutrients and risk of breast cancer. Lancet 347, 1351–1356, 1996.
- Pelucchi C, Galeone C, Talamini R, Negri E, Polesel J, et al.: Dietary acrylamide and pancreatic cancer risk in an Italian case-control study. Ann Oncol 22, 1910–1915, 2011.